| 【英語論文】 |
| |
原著論文 |
| |
|
1.Hayakawa K, Nakano R, Hase R, Shimatani M, Kato H, Hasumi J, Doi A, Sekiya N, Nei T, Okinaka K, Kasahara K, Kurai H, Nagashima M, Miyoshi-Akiyama T, Kakuta R, Yano H, Ohmagari N. Comparison between IMP carbapenemase-producing Enterobacteriaceae and non-carbapenemase-producing Enterobacteriaceae: a multicentre prospective study of the clinical and molecular epidemiology of carbapenem-resistant Enterobacteriaceae. J Antimicrob Chemother. 2020;75(3):697-708. |
| |
|
2.Itoh N, Hadano Y, Yamamoto Y, Terada N, Kurai H. Infectious disease specialist consultations in a Japanese cancer center: a retrospective review of 776 cases. BMC Health Serv Res. 2020;20(1):500. |
| |
|
3.Kusama Y, Muraki Y, Mochizuki T, Kurai H, Gu Y, Ohmagari N. Relationship between drug formulary and frequently used cephalosporins, macrolides and quinolones in Japanese hospitals. J Infect Chemother. 2020;26(2):211-5. |
| |
|
4.Terada N, Itoh N, Kurai H. Effectiveness of oral antibiotics for treating pyelonephritis caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae: A case series. J Gen Fam Med. 2020;21(4):127-33. |
| |
|
5.Yamamoto Y, Itoh N, Sugiyama T, Kurai H. Clinical features of Clostridium bacteremia in cancer patients: A case series review. J Infect Chemother. 2020;26(1):92-4. |
| |
|
6.Yamamoto Y, Terada N, Sugiyama T, Kurai H, Ohkusu K. Neisseria macacae bacteremia: report of two cases with a literature review. BMC Infect Dis. 2020;20(1):619. |
